Position in GILD
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,234,649,812
-$234,186,085 QoQ
Shares Held
9,772,438
-7.3% QoQ
Ownership
0.788%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#22
of 2,275 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Amundi holds $20,539,050,875 across 14 Drug Manufacturers - General names. GILD ranks #7 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,808,143 | $5,767,031,432 | |
| 2 | JNJ |
Johnson & Johnson
|
13,117,657 | $3,331,491,343 | |
| 3 | AZN |
Astrazeneca PLC
|
16,422,784 | $3,114,088,296 | |
| 4 | ABBV |
AbbVie Inc.
|
10,039,289 | $2,526,286,678 | |
| 5 | MRK |
Merck & Co., Inc.
|
12,342,274 | $1,585,982,207 | |
| 6 | AMGN |
Amgen Inc
|
3,890,189 | $1,408,715,236 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
9,772,438 | $1,234,649,812 | |
| 8 | PFE |
Pfizer Inc
|
33,533,616 | $807,489,467 |
All Filings in GILD
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,234,649,812 | 9,772,438 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $1,468,835,897 | 10,539,111 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $1,168,501,365 | 9,520,135 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $841,799,691 | 7,583,781 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,160,521,853 | 10,467,411 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $991,984,912 | 8,853,056 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $833,195,768 | 9,020,199 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $1,141,597,871 | 13,616,387 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $771,212,684 | 11,240,529 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $695,920,113 | 9,500,616 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $852,270,068 | 10,520,554 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $794,563,181 | 10,602,658 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $841,564,468 | 10,919,482 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $881,563,043 | 10,625,082 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $874,620,904 | 10,187,780 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $629,802,329 | 10,209,148 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $499,606,692 | 8,082,943 | Shares | Defined | 2022-09-02 | |
| 2022-03-31 | $405,177,299 | 6,815,430 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $619,321,895 | 8,529,430 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $729,479,589 | 10,443,516 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $607,734,311 | 8,825,651 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||